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may be because cases of gul dependence are usually 
not brought for consultation to the psychiatrists. It 
has been our experience that there is usually an 
increase in the symptomatic abuse of this product in 
psychotic disorders and episodes of depressive ill-
ness. This report is an effort to bring to the notice of 
researchers in the field of psychiatry and related 
fields, the endemic abuse of this substance - a hither-
to unrecognized but widely prevalent problem. 
SayeedAkhtar 
Christoday RJ. KHess 
Central Institute of Psychiatry 
Kanke, Ranchi 834 006. 
PHYSICAL MORBIDITY AND UNMODIFIED 
ECT 
Sir, 
We read with interest the article by Drs. Tharyan 
et al (Journal, Oct 1993). It is a commendable at-
tempt at documenting the experience with un-
modified ECT in a center that has been compelled 
to use the same under severe resource constraints. It 
offers a useful body of information to other 
psychiatrists, in a similar predicament, who have no 
choice but to make the best of a bad situation, 
conscious of the limits of safety. The authors, how-
ever, have deflected the debate by telescoping into 
their discussion issues of desirability and com-
parability vis-a-vis the currently accepted standard 
of modified ECT. It appears that in their anxiety to 
legitimize unmodified ECT and reassure themsel-
ves, they have exceeded the limits of valid inference. 
They observed that unmodified ECT in a selected 
population (after screening out those requiring 
modified ECTs) is not very unsafe except for frac-
tures in about 0.8% of patients. Although they 
recorded one death with cardiac arrest, the authors 
comment that the treatment is safer than modified 
ECT. This remark we opine is without sufficient 
basis. First, the two ECT comparisons were not 
strictly random. Second, by virtue of screening some 
patients for only modified ECT, this group is dif-
ferent from the larger unmodified ECT group. As 
can be seen by their data, the upper age range in the 
modified ECT group was 70 years whereas it was 50 
years for the unmodified ECT group. Third, the 
modification procedures are not clearly described, 
eg., the dose of atropine if used should have been 
given. 
The authors have not made a data-based case to 
justify the implication that "the recommendation to 
routinely give only modified ECT requires further 
review". The debate needs to be addressed with truly 
comparable data, on both morbidity and accept-
ability of the two procedures. Meanwhile, 
psychiatrists owe to their patients to advocate and 
strive to offer them the best current standards of care 
including modified ECT. 
B. N. Gangadhar 
N. Janakiramaiah 
Department of Psychiatry 
NIMHANS 
Bangalore 560 029. 
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THARYAN ET AL REPLY 
Sir, 
We appreciate the interest shown by Gangadhar 
& Janakiramaiah in our paper on unmodified ECT, 
the main aim of which was to stimulate a debate on 
the routine use of modified ECT in this country, 
given the paucity of anaesthetic and resuscitative 
facilities in many centers where ECT is ad-
ministered. However, their comments on the validity 
of our inference appear based primarily on the as-
sumption that the patients in our study treated with 
modified ECT were older and less physically fit than 
those treated with unmodified ECT. 
The first assumption is erroneous as the data in 
Table 1 of our paper clearly states that the upper age 
range of 70 years and 59 years pertain to patients 
treated with unmodified ECT, who experienced 
myalgia or fractures respectively, and not to patients 
given modified ECT. The difference in the mean 
ages of patients in the two treatment groups was not 
significant. The second assumption is partly true in 
the observation that patients in our series treated 
with modified ECT had a higher prevalence of pre-
existing musculoskeletal complications; however, 
as highlighted in our paper, unmodified ECT was 
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given uneventfully to patients with a variety of 
coexisting cardiac, respiratory, metabolic and 
neurological disorders. Thus, though not randomly 
allocated, a selection bias would not explain the 
higher cardiac morbidity in patients treated with 
modified ECT. 
The modification procedure we follow consists 
of hyperventilation with 100% oxygen prior to and 
after the stimulus, the use of hypnotic doses of 
thiopentone in the range of 100-300 mgs, muscle 
relaxation with 25-30 mgs of succinylcholine 
chloride (0.5 mgs/kg body weight), monitoring of 
seizure duration by the cuff method, and main-
tenance of a patent airway. Atropine is given as 
premedication for both modified as well as un-
modified ECT in a standard dose of 0.6 mgs in-
tramuscularly, 30 minutes prior to treatment; though 
this dose may be considered inadequate to prevent 
vagally stimulated arrhythmias (Allen et al, 1982), 
there is still a lack of evidence regarding the efficacy 
and need for routine anticholinergic premedication 
(American Psychiatric Association, 1990). 
The focus of our study was on whether modified 
ECT is routinely indicated and our findings of less 
than 1% physical morbidity when unmodified ECT 
is administered by a trained team suggests that from 
a clinical stand point, modification of ECT is indi-
cated primarily in the event of coexisting musculo-
skeletal disorders (2% of our cases). The change 
from unmodified to modified ECT in the west oc-
curred largely due to socio-political and medico-
legal reasons, but despite changes in technique, 
public attitudes to ECT have changed but little (Fox, 
1993). The mortality of ECT actually increased 
sharply when modified ECT came into general use 
in the early 1950's and was largely attributable to 
ill-equipped psychiatrists assuming the role of anes-
thetists (Maclay, 1953). Modern ECT in the west is 
undoubtedly safe but is performed in well equipped 
settings under the supervision of anesthetists and 
involves a small number of patients at each session. 
This is far removed from the conditions under which 
ECT is administered in many centers in this country. 
Until data on the frequency of complications on 
modified ECT are made available from centers 
where it is routinely administered, and especially 
where psychiatrists are solely responsible for anaes-
thesia, it remains unclear what would be considered 
"the best current standards of care" with reference to 
ECT in the Indian context. 
Our study remains the only attempt to provide 
data relevant to this issue and we reiterate our con-
clusion that the recommendation to routinely modify 
ECT is premature and requires further review. 
Prathap Tharyan 
PJSaju 
SunilDatta 
Jacob K John 
K. Kuruvilla 
Department of Psychiatry 
Christian Medical College 
Vellore632 002. 
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